Please join us for our Scientific Symposium on Sept. 10 (Auditorium 2) and at Booth 53 at the Centre de Convencions Internacional de Barcelona to learn about our new products and clinical data

Increased length and 1200 PSI rating provides for additional access in patient procedures and enables higher injection pressure for improved angiographic imaging

Study presented at SIR shows Surefire Medical technology achieves 80% complete tumor response, effective in downstaging patients to transplant

Led by Tullis Health Investors, the round will be used for a global launch of the new Surefire Precision Infusion System